Abstract
The role of opioid systems in the anticonflict effect of chlordiazepoxide, diazepam and pentobarbital was evaluated with a modified Vogel procedure. First, morphine, ineffective by itself, was combined with subeffective or marginally effective doses of the benzodiazepines in order to detect possible potentiation. However, the combined treatment reduced licking in the Vogel procedure as well as in a licking test where no shock was administered. Several doses of the benzodiazepines and pentobarbital were then administered in combination with several doses of the opiate antagonist naloxone. A dose-dependent inhibition of anticonflict effect was obtained. In an additional experiment, it was shown that naloxone blocked the effects of diazepam in the elevated plus-maze procedure. Motor deficiencies, as evaluated with a rotarod test, produced by the benzodiazepines and pentobarbital could not be antagonized by naloxone. It is concluded that opioids are important for the anticonflict but not for the motor effects of these drugs. An analysis of published studies concerning the interaction of opioids and benzodiazepines in several procedures supposed to reflect anxiolytic effects shows that the inhibition obtained with naloxone is reliable and not procedure specific. The mechanisms by which opiate antagonists produce this inhibition of anticonflict activity are not known. It is tentatively suggested that opioid activation associated with stress may be a necessary component of anxiolysis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ågmo A, Fernandez H (1991) Benzodiazepine receptor ligands and sexual behavior in the male rat: the role of GABAergic mechanisms. Pharmacol Biochem Behav 38:781–788
Ågmo A, Tarasco C (1985) Interactions between naloxone and GABA in the control of locomotor activity in the rat. J Neural Transm 61:137–149
Ågmo A, Paredes R, Fernandez H (1987) Differential effects of GABA transaminase inhibitors on sexual behavior, locomotor activity, and motor execution. Pharmacol Biochem Behav 28:47–52
Ågmo A, Pruneda R, Guzman M, Gutiérrez M (1991) GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines. Naunyn-Schmiedeberg's Arch Pharmacol 344:314–322
Ågmo A, Rojas J, Vazquez P (1992) The inhibitory effects of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system. Psychopharmacology 107:89–96
Billingsley ML, Kubena RK (1978) The effects of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines. Life Sci 22:897–906
Brady KT, Lydiard RB, Ballenger JC, Shook J, Laraia M, Fossey M (1991) CSF opioids in panic disorder. Biol Psychiatry 30:512–514
Britton DR, Britton KT, Dalton D, Vale W (1981) Effects of naloxone on anticonflict and hyperphagic actions of diazepam. Life Sci 29:1297–1302
Brown BS, Chaitkin L (1981) Use of stimulant/depressant drugs by drug abuse clients in selected metropolitan areas. Int J Addict 16:1473–1490
Brown DR, Robertson MJ, Goldberg LI (1983) Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives. Neuropharmacology 22:317–321
Cannizaro G, Flugy A, Novara V, Provenzano PM (1987) Interaction between naloxone, chlordiazepoxide and valproic acid evaluated by emotional operant behaviour in the rat. Arzneimittelforschung 37:6–9
Carlsson KR, Seeger TF (1982) Interaction of opiates with dopamine receptors: receptor binding and behavioral assays. Pharmacol Biochem Behav 16:119–124
Cohen GA, Doze VA, Madison DV (1992) Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal neurons. Neuron 9:325–333
Cooper SJ (1983) Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behavior. Life Sci 32:1043–1051
Cooper SJ, McGivern H (1983) Effects of naloxone and naltrexone on the increased water intake and drinking duration in phenobarbitone-treated rats. Psychopharmacology 79:25–28
Darke S, Swift W, Hall W, Ross M (1993) Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend 34:67–70
Dingledine R, Iversen LL, Breuker E (1978) Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. Eur J Pharmacol 47:19–27
Doble A, Martin IL (1992) Multiple benzodiazepine receptors: no reason for anxiety. Trends Pharmacol Sci 13:76–81
Donzanti BA, Althaus JS, Payson MM, Von Voigtlander PF (1992) Kappa agonist-induced reductions in dopamine release: site of action and tolerance. Res Commun Chem Pathol Pharmacol 78:193–210
Duka T, Wüster M, Herz A (1979) Rapid changes in enkephalin levels in rat striatum and hypothalamus induced by diazepam. Naunyn-Schmiedeberg's Arch Pharmacol 309:1–5
Duka T, Wüster M, Herz A (1980) Benzodiazepines modulate striatal enkephalin levels via a GABAergic mechanism. Life Sci 26:771–776
Duka T, Cumin R, Haefely W, Herz A (1981) Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats. Pharmacol Biochem Behav 15:115–117
File SE (1982) Chlordiazepoxide-induced ataxia, muscle relaxation and sedation in the rat: effects of muscimol, picrotoxin and naloxone. Pharmacol Biochem Behav 17:1165–1170
Forman LJ, Estilow-Isabell S, Harwell M, de Salvo S, Cater J (1991) Possible opiate action in the anxiolytic and antinociceptive actions of alprazolam. Res Commun Chem Pathol Pharmacol 71:259–271
Friedman SB, Adler R, Grota LJ, Larson T (1967) Plasma corticosterone response to parameters of electric shock in rats. Psychosom Med 29:323–328
Gardner CR (1988) Potential use of drugs modulating 5-HT activity in the treatment of anxiety. Gen Pharmacol 19:347–356
Gilbert PE, Martin WR (1977) Antagonism of the effects of pentobarbital in the chronic spinal dog by naloxone. Life Sci 20:1401–1406
Giusti P, Arban R (1993) Physiological and pharmacological bases for the diverse properties of benzodiazepines and their congeners. Pharmacol Res 27:201–215
Goldinger A, Müller WE, Wollert U (1981) Inhibition of glycine and GABA receptor binding by several opiate agonists and antagonists. Gen Pharmacol 12:477–479
Goldstein A (1987) Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors. Trends Pharmacol Sci 8:456–460
Gomar MD, Castillo JL, del Aguila C, Fernández B, Acuna-Castroviejo D (1993a) Intracerebroventricular injection of naloxone blocks melatonin-dependent brain3H-flunitrazepam binding. Neuroreport 4:987–990
Gomar MD, Fernández B, Castillo JL, del Aguila C, Acuna-Castroviejo D (1993b) Suppressive effect of simultaneous injection of ACTH1–10 and β-endorphin on brain3H-flunitrazepam binding. Neuroreport 5:252–254
Gruen RJ, Friedhoff AJ, Coale A, Moghaddam B (1992) Tonic inhibition of striatal dopamine transmission: effects of benzodiazepine and GABAA receptor antagonists on extracellular dopamine levels. Brain Res 599:51–56
Harris JA, Westbrook RF (1994) Effects of midazolam and naloxone in rats tested for sensitivity/reactivity to formalin pain in a familiar, novel or aversively conditioned environment. Psychopharmacology 115:65–72
Harsing LG, Yang HY, Costa E (1982) Evidence for γ-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of met5-enke-phalin elicited by depolarisation. J Pharmacol Exp Ther 220:616–620
Herling S (1983) Naltrexone blocks the response-latency increasing effects but not the discriminative effects of diazepam in rats. Eur J Pharmacol 88:121–124
Jacquet YF, Saederup E, Squires RF (1987) Non-stereospecific excitatory actions of morphine may be due to GABAA receptor blockade. Eur J Pharmacol 138:285–288
Johnson SW, North RA (1992) Opiods excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483–488
Kleber HD, Gold MS (1978) Use of psychotropic drugs in treatment of methadone maintained narcotic addicts. Ann NY Acad Sci 311:81–98
Koob GF, Strecker RE, Bloom FE (1980) Effects of naloxone on the anticonflict properties of alcohol and chlordiazepoxide. Subst Alcohol Actions/Misuse 1:447–457
Lerner T, Feldon J, Myslobodsky MS (1986) Amphetamine potentiation of anti-conflict action of chlordiazepoxide. Pharmacol Biochem Behav 24:241–246
Levine AS, Morley JE, Gosnell BA, Billington CJ, Bartness TJ (1985) Opioids and consummatory behavior. Brain Res Bull 14:663–672
Larsen PJ, Mau SE (1994) Effect of acute stress on the expression of the hypothalamic messenger ribonucleic acids encoding the endogenous opioid precursors preproenkephalin A and proopiomelanocortin. Peptides 15:783–790
Lopez F, Miller LG, Thompson ML, Schatzki A, Chesley S, Greenblatt DJ, Shader RI (1990) Chronic morphine administration augments benzodiazepine binding and GABAA receptor function. Psychopharmacology 101:545–549
Lorens SA, Sainati SM (1978) Naloxone blocks the excitatory effects of ethanol and chlordiazepoxide on lateral hypothalmic self-stimulation. Life Sci 23:1359–1364
Maccari S, Piazza PV, Deminière JM, Lemaire V, Mormède P, Simon H, Angelucci L, Le Moal M (1991) Life events decrease of corticosteroid type I receptors is associated with reduced vulnerability to amphetamine self-administration. Brain Res 547:7–12
Maier SF (1990) Diazepam modulation of stress-induced analgesia depends on the type of analgesia. Behav Neurosci 104:339–347
Maier SF, Ryan SM, Barksdale CM, Kalin NH (1986) Stressor controllability and the pituitary-adrenal system. Behav Neurosci 100:669–674
Manzanares J, Lookingland KJ, Moore KE (1991) Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain. J Pharmacol Exp Ther 256:500–505
Martin DC, Introna RP, Aronstam RS (1991) Fentanyl and sufentanyl inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain. Neuropharmacology 30:323–327
Millan MJ, Duka T (1981) Anxiolytic properties of opiates and endogenous opioid peptides and their relationship to the actions of benzodiazepines. Mod Probl Pharmacopsychiatry 17:123–141
Miller LG, Thompson ML, Greenblatt DJ, Deutsch SI, Shader RI, Paul SM (1987) Rapid increase in benzodiazepine binding following defeat stress in mice. Brain Res 414:395–400
Misra AL, Pontani RB, Vadlamani NL, Mulé SJ (1976) Physiological disposition and biotransformation of allyl-1′-3′-14C naloxone in the rat and some comparative observations on nalorphine. J Pharmacol Exp Ther 196:257–268
Möhler H, Okada T (1977) Benzodiazepine receptor: demonstration in the CNS. Science 198:849–851
Naruse T, Asami T, Koizumi Y (1989) Effects of naloxone and picrotoxin on diazepam- or pentobarbital-induced hyperphagia in nondeprived rats. Pharmacol Biochem Behav 31:709–711
Nicoll RA, Alger BE, Jahr CE (1980) Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature 287:22–25
Olsen RW, Leeb-Lundberg F (1981) Convulsant and anticonvulsant drug binding sites related to the GABA receptor/ionophore system. In: Morselli PL, Lloyd KG, Löscher W, Meldrum B, Reynolds EH (eds) Neurotransmitters, seizures and epilepsy. Raven, New York, pp 151–164
Olson GA, Olson RD, Kastin AJ (1993) Endogenous opioids: 1992. Peptides 14:1339–1378
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167
Pollard GT, Howard JL (1990) Effects of drugs on punished behavior: pre-clinical test for anxiolytics. Pharmacol Ther 45:401–424
Reid LD (1985) Endogenous opioid peptides and regulation of drinking and feeding. Am J Clin Nutr 42:1099–1132
Reinhard Jr JF, Bannon MJ, Roth RH (1982) Acceleration by stress of dopamine synthesis and metabolism in prefrontal cortex: antagonism by diazepam. Naunyn-Schmiedeberg's Arch Pharmacol 318:374–377
Schaefer GJ (1988) Opiate antagonists and rewarding brain stimulation. Neurosci Biobehav Rev 12:1–17
Shephard RA (1986) Neurotransmitters, anxiety and benzodiazepines: a behavioral review. Neurosci Biobehav Rev 10:449–461
Spyraki C, Kazandjian A, Varonos D (1985) Diazepam-induced place preference conditioning: appetitive and antiaversive properties. Psychopharmacology 87:225–232
Soubrié P, Jobert A, Thiebot MH (1980) Differential effects of naloxone against the diazepam-induced release of behavior in rats in three aversive situations. Psychopharmacology 69:101–105
Stitzer ML, Griffiths RR, McLellan AT, Grabowski J, Hawthorne JW (1981) Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend 8:189–199
Taylor DP, Riblet LA, Stanton HC, Eison AS, Eison MS, Temple Jr DL (1982) Dopamine and antianxiety activity. Pharmacol Biochem Behav 17 [Suppl. 1]:25–35
Tepperman FS, Hirst M, Smith P (1983) Brian and serum levels of naloxone following peripheral administration. Life Sci 33:1091–1096
Tokuyama S, Takahashi M, Kaneto H. (1989) Blockade of the development of analgesic tolerance to morphine by psychological stress through benzodiazepine receptor mediated mechanisms. Jpn J Pharmacol 51:425–427
Tripp G, McNaughton N (1987) Naloxone fails to block the effects of chlordiazepoxide on acquisition and performance of successive discrimination. Psychopharmacology 91:119–121
Tripp G, McNaughton N (1991) Naloxone and chlordiazepoxide: effects on acquisition and performance of signalled punishment. Pharmacol Biochem Behav 38:43–47
Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1–7
Wüster M, Duka T, Herz A (1980) Diazepam effects on striatal met-enkephalin levels following long-term pharmacological manipulations. Neuropharmacology 19:501–505
Author information
Authors and Affiliations
Additional information
Part of this study was presented at the Society for Neuroscience Annual Meeting, Washington DC, USA, November 7–12, 1993.
Rights and permissions
About this article
Cite this article
Ågmo, A., Galvan, A., Heredia, A. et al. Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review. Psychopharmacology 120, 186–194 (1995). https://doi.org/10.1007/BF02246192
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246192